pubrio
BeiGene logo

BeiGene

Public
+1
beigene.com
生物技術研究3,000+ employeesFounded 2010🇺🇸 美國

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.

成立年份
2010
員工
3,000+
行業
生物技術研究
公司類型
Public Company
股票
nasdaq: BGNE
總部
🇺🇸Cambridge, MA (+21)
專長
製藥產業生物技術醫療保健生物技術研究

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 BeiGene 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中

活動脈搏

全新 招聘 活動 — 剛出現 1 個新訊號。

過去 90 日
招聘
1新增
招聘
市場推廣與公關
0
無活動
產品與技術
1新增
產品發布
+2個類別已鎖定
已顯示 5 個中的 3 個
值得了解

關於 BeiGene 的常見問題

關於 BeiGene 業務、市場及增長訊號的快速解答。

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。